Piper Sandler raised the firm’s price target on Labcorp (LH) to $280 from $260 and keeps a Neutral rating on the shares. The firm updated the company’s model post the earnings report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH:
- Positive Outlook for Labcorp Holdings: Buy Rating Affirmed Amid Solid Growth and Strategic Moves
- Labcorp price target raised to $267 from $253 at Baird
- Labcorp price target raised to $250 from $240 at Barclays
- Labcorp’s Resilience and Growth Potential: A Reliable Investment Choice Despite Revenue Miss
- Labcorp Holdings: Strong Q1 2025 Performance and Positive Outlook Justify Buy Rating